Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Pediatr Otorhinolaryngol ; 126: 109597, 2019 Nov.
Article in English | MEDLINE | ID: mdl-31351349

ABSTRACT

OBJECTIVES: Myringosclerosis commonly occurs as a long-term complication of ventilation during the treatment of otitis media. We aimed to determine the effects of rosmarinic acid as an antioxidant on experimentally induced myringosclerosis. METHODS: Twenty-four male Sprague-Dawley rats, weighing 250-300 g, were unilaterally myringotomized and randomly separated into three groups. Group 1 received no treatment (control group) (n = 8); Group 2 received topical rosmarinic acid (n = 8); Group 3 received oral rosmarinic acid (n = 8). On the twenty-first day, the right ears were examined by otomicroscope and findings of myringosclerosis were recorded. Finally, all of the rats were euthanized and the tympanic membrane (TM) thickness and the severity of middle ear mucosal inflammation were evaluated histopathologically. RESULTS: The myringosclerosis severity, TM thickness, and inflammation scores were found to be significantly higher in the control group than in the topical and systemic treatment groups (p < 0.05). There were no statistically significant differences in terms of TM thickness and inflammation scores between the topical and systemic treatment groups (p > 0.05). While moderate and severe myringosclerosis were higher in the control group, mild myringosclerosis was found to be higher in both treatment groups. CONCLUSION: The local and oral administration of rosmarinic acid suppressed inflammation, reduced TM thickness, and prevented the development of myringosclerosis in myringotomized rats.


Subject(s)
Antioxidants/therapeutic use , Cinnamates/therapeutic use , Depsides/therapeutic use , Myringosclerosis/prevention & control , Postoperative Complications/prevention & control , Tympanic Membrane/drug effects , Administration, Oral , Administration, Topical , Animals , Antioxidants/pharmacology , Cinnamates/pharmacology , Depsides/pharmacology , Male , Middle Ear Ventilation/adverse effects , Myringosclerosis/etiology , Random Allocation , Rats , Rats, Sprague-Dawley , Treatment Outcome , Tympanic Membrane/pathology , Rosmarinic Acid
2.
Biomed Res Int ; 2017: 5796456, 2017.
Article in English | MEDLINE | ID: mdl-29201908

ABSTRACT

OBJECTIVES: We aimed to investigate the effect of a carbohydrate-rich diet on detrusor contractility in rats. MATERIALS AND METHODS: Sprague-Dawley rats were randomized into two groups. The control group received regular food and water. The study group received carbohydrate-rich diet for six weeks. The rats' detrusor muscle was isolated for pharmacological and histopathological examinations. RESULTS: In the control and study groups, mean body weights were 431.5 ± 27.6 g and 528.0 ± 36.2 g, respectively (p < 0.001). Electrical stimulation of the detrusor strips of the control group resulted in gradual contraction. A decreased contractile response was shown in the study group. Acetylcholine in 10-7-10-3 molar concentration produced a decreased contractile response in the study group, compared to the control group (p < 0.01). The study group showed marked subepithelial and intermuscular fibrosis in the bladder. CONCLUSION: Carbohydrate-rich diet causes marked subepithelial and extracellular fibrosis and changes in contractility in the detrusor within a six-week period. Changes have higher costs in therapeutic choices and correction of these changes remains difficult. Putting an end to carbohydrate-rich diet would seem to be more cost-effective than dealing with the effects of consuming it in high proportions which should be the national policy worldwide.


Subject(s)
Fibrosis/physiopathology , Muscle Contraction/drug effects , Muscle, Smooth/physiopathology , Urinary Bladder, Overactive/physiopathology , Animals , Diet/adverse effects , Dietary Carbohydrates/adverse effects , Fibrosis/chemically induced , Humans , Muscle Contraction/physiology , Muscle, Smooth/drug effects , Rats , Urinary Bladder/physiopathology , Urinary Bladder, Overactive/chemically induced
3.
Int J Pediatr Otorhinolaryngol ; 95: 127-132, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28576521

ABSTRACT

OBJECTIVE: To investigate the effects of caffeic acid phenethyl ester (CAPE) on tympanosclerosis. MATERIALS AND METHODS: Thirty-two male Sprague Dawley rats were separated into 4 groups as CAPE (n = 10), alcohol (n = 10), control (n = 8) and normal (n = 4) groups. All tympanic membranes except normal group were myringotomised and type 3 Streptococcus pneumoniae strains was injected into their middle ears. Myringotomies were repeated for 5 weeks. Intraperitoneal (i.p) CAPE were administrated to the CAPE group at 10 µmol/kg/day and 10% ethyl alcohol administrated to the alcohol group for 5 weeks. The control group were left untreated. Findings of myringosclerosis were recorded by otomicroscope at sixth week. Then, all rats were sacrificed and tympanic membrane thickness and severity of middle ear mucosal inflammation evaluated histopathalogically. RESULTS: Severity of myringosclerosis was significantly higher in the alcohol and control groups compared to the CAPE group (p < 0.001), but was not significant when alcohol and control groups were compared (p = 0.17). The tympanic membrane thickness measured in the alcohol and control groups were significantly higher compared to the CAPE group (p < 0.001), but was not significant when alcohol and control groups were compared (p = 0.17). The severity of inflammation in the middle ear mucosa was significantly higher in the alcohol and control groups compared to the CAPE group (respectively, p < 0.001, p = 0.03). The severity of inflammation in the middle ear mucosa was not significant between alcohol and control groups (p = 0.30). CONCLUSION: CAPE has anti-inflammatory and antioxidant effects on the development of MS in myringotomized rats, so reduces the severity of tympanosclerosis.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology , Caffeic Acids/pharmacology , Myringosclerosis/drug therapy , Phenylethyl Alcohol/analogs & derivatives , Tympanic Membrane/drug effects , Animals , Inflammation/drug therapy , Male , Middle Ear Ventilation , Phenylethyl Alcohol/pharmacology , Rats , Rats, Sprague-Dawley , Tympanic Membrane/pathology
4.
Indian J Pharmacol ; 49(1): 102-109, 2017.
Article in English | MEDLINE | ID: mdl-28458432

ABSTRACT

OBJECTIVES: Irrational drug use results in drug interactions, treatment noncompliance, and drug resistance. Rational pharmacotherapy education is being implemented in many faculties of medicine. Our aim is to introduce rational pharmacotherapy education by clinicians and to evaluate task-based rational drug therapy education in the clinical context. METHODS: The Kirkpatrick's evaluation model was used for the evaluation of the program. The participants evaluated the program in terms of constituents of the program, utilization, and contribution to learning. Voluntary participants responded to the evaluation forms after the educational program. Data are evaluated using both quantitative and qualitative tools. SPSS (version 21) used for quantitative data for determining mean and standard deviation values. Descriptive qualitative analysis approach is used for the analysis of open-ended questions. RESULTS: It was revealed that the program and its components have been favorable. A total 95.9% of the students consider the education to be beneficial. Simulated patients practice and personal drug choice/problem-based learning sessions were appreciated by the students in particular. 93.9% of the students stated that all students of medicine should undergo this educational program. Among the five presentations contained in the program, "The Principles of Prescribing" received the highest points (9 ± 1.00) from participating students in general evaluation of the educational program. CONCLUSION: This study was carried out to improve task-based rational drug therapy education. According to feedback from the students concerning content, method, resource, assessment, and program design; some important changes, especially in number of facilitators and indications, are made in rational pharmacotherapy education in clinical task-based learning program.


Subject(s)
Drug Therapy , Education, Medical/methods , Problem-Based Learning/methods , Students, Medical , Educational Measurement , Female , Humans , Male , Patient Simulation , Turkey
5.
Indian J Pharmacol ; 48(2): 150-4, 2016.
Article in English | MEDLINE | ID: mdl-27114637

ABSTRACT

OBJECTIVES: To investigate nonsteroidal anti-inflammatory drugs effectiveness in colorectal distension (CRD)-induced visceral pain model. MATERIALS AND METHODS: Male Sprague-Dawley (250-300 g) rats were anesthetized with ketamine (50 mg/kg, intraperitoneally [i.p.]) and chlorpromazine (25 mg/kg, i.p.). Two bipolar Teflon-coated Ni/Cr wire electrodes (80-M diameter) were placed in the abdominal external oblique muscle for the recording of electromyography. Jugular vein catheter was placed for the administration of drugs. CRD method was applied to evaluate of visceral pain. All drugs (paracetamol, meloxicam, metamizole, and dexketoprofen) administered intravenously. RESULTS: Paracetamol 200, 400, and 600 mg/kg did not change the visceromotor response (VMR) when compare with the control group. Meloxicam 2 and 4 mg/kg showed no effect but at doses of 6 mg/kg meloxicam significantly ([51.9 ± 6.4%] [P < 0.001]) decreased VMR compared with the control group. Metamizole 200 mg/kg did not change responses but dose of 400 and 600 mg/kg metamizole reduced VMR. Dexketoprofen 2 and 4 mg/kg did not cause a change in VMR but 6 mg/kg dose significantly reduced response compared with the control group ([43.9 ± 3.9%, 36.8 ± 2.8%, 34.8 ± 2.5%, 42.1 ± 4.8%, 40.7 ± 3.5%, 36.4 ± 2.7%, and 26.1 ± 2.2%]; from 10 min to 70 min, respectively, [P < 0.05]). CONCLUSION: Metamizole, dexketoprofen and meloxicam show antinociceptive effect with different duration of action on CRD-induced visceral pain model. This condition can be explained due to different chemical structures and different mechanisms which play a role in modulation of pain.


Subject(s)
Analgesics/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Visceral Pain/drug therapy , Animals , Dose-Response Relationship, Drug , Male , Rats , Rats, Sprague-Dawley , Visceral Pain/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...